High prevalence and resistance rates of Mycoplasma genitalium among patients visiting two sexually transmitted infection clinics in the Netherlands.
David J HetemSophie Kuizenga WesselSylvia M BruistenJoyce F BraamMartijn S van RooijenClarissa E VergunstRoel Ht NijhuisMary BernsJean-Marie BrandAlje P van DamPublished in: International journal of STD & AIDS (2021)
Mycoplasma genitalium is a well-known cause of urethritis in men and has been associated with cervicitis, pelvic inflammatory disease, and adverse obstetric outcomes in women. In this cross-sectional study, we determined the current prevalence of M. genitalium infection and the rate of macrolide resistance in M. genitalium isolates, in patients visiting two large Dutch sexually transmitted infection (STI) clinics, to evaluate whether the recommendations in Dutch guidelines should be revised. In addition, risk factors for M. genitalium were identified. In total, 3225 patients were included. M. genitalium prevalence rates were 13.8% for all patients; 20.1% for men who have sex with men, 8.2% for men who have sex with women, and 12.6% for women. Macrolide resistance-associated mutations were detected in 66% of the patients infected with M. genitalium. Age, educational level, country of origin, number of sexual partners, HIV-positivity, infection with Neisseria gonorrhoeae, and urethral symptoms in men were independently associated with M. genitalium infection. In conclusion, we found very high prevalence rates and macrolide resistance rates of M. genitalium in patients visiting STI clinics.
Keyphrases
- end stage renal disease
- men who have sex with men
- ejection fraction
- newly diagnosed
- chronic kidney disease
- prognostic factors
- primary care
- hiv positive
- risk factors
- pregnant women
- hiv testing
- emergency department
- patient reported outcomes
- skeletal muscle
- hiv aids
- south africa
- electronic health record
- insulin resistance